Several studies have demonstrated the presence of oligomers of P-glycoprotein in multidrug-resistant cells. The minimum functional unit of P-glycoprotein, however, is not known. In order to determine whether the functional unit is an oligomer, we tested for associations between P-glycoproteins containing either a histidine tag or the epitope tag for monoclonal antibody A52 at the COOH-terminal end of the molecule. Both tagged molecules were active and had indistinguishable drug resistance profiles. The tagged P-glycoproteins were expressed contemporaneously in HEK 293 cells, purified by nickel-chelate chromatography followed by immunoblot analysis. We found that P-glycoprotein-A52 did not copurify with functionally active P-glycoprotein-(His) 10 , even when the former was overexpressed relative to the histidine-tagged protein. Similar results were obtained with phosphorylation-deficient mutants of P-glycoprotein. By contrast, we could purify and reconstitute drugstimulated ATPase activity when the half-molecules NH 2 -terminal half-(His) 10 /COOH-terminal half-A52 or NH 2 -terminal half-A52/COOH-terminal half-(His) 10 were coexpressed in HEK 293 cells. These results suggest that nickel-chelate chromatography may be a suitable method for studying protein-protein interactions in membrane proteins and that the minimal functional unit of P-glycoprotein is likely to be a monomer. P-glycoprotein is an ATP-dependent pump that transports a wide range of cytotoxic compounds out of the cell (1, 2). It may be one of several mechanisms responsible for multidrug resistance during chemotherapy. P-glycoprotein is expressed in a wide variety of tissues and cells. Its physiological role is unknown but it may act to protect the organism from endogenous and exogenous cytotoxic compounds. This is supported by studies on "knock-out" mice that were homozygous for a disruption of the mdr1a gene (3-5).Cloning and sequencing of human MDR1 (6) showed that P-glycoprotein contains 1280 amino acids organized into two tandem repeats of 610 amino acids joined by a linker region of 60 amino acids. Each repeat consists of an NH 2 -terminal hydrophobic domain containing six potential transmembranespanning helices followed by a hydrophilic domain containing a nucleotide-binding site. The arrangement is supported by the results of topology studies on the full-length molecule (7,8).The mechanism by which P-glycoprotein is able to couple ATP hydrolysis to the efflux of a broad range of lipophilic compounds is unknown. Although each half-molecule of Pglycoprotein possesses basal ATPase activity, drug-stimulated ATPase activity was only observed when both halves were expressed contemporaneously (9). Both nucleotide-binding sites are also essential for function since mutations in either site (10, 11) or chemical modification of either site (12, 13) inactivates any coupling of ATPase activity to drug binding. P-glycoprotein has been detected to be present in the membrane in the form of monomers, dimers, and higher oligomers (14 -17). In the membranes of...